Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors

Clinical trial NCT00622674 · COMPLETED

Trial details

NCT number: NCT00622674
Sponsor: Masonic Cancer Center, University of Minnesota
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer Colorectal Cancer Head and Neck Cancer Kidney Cancer Lung Cancer Pancreatic Cancer Sarcoma Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2005-11-01
Primary completion: 2009-08-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.